Vibrational fiber photometry: label-free and reporter-free minimally invasive Raman spectroscopy deep in the mouse brain.

Optical approaches to monitor neural activity are transforming neuroscience, owing to a fast-evolving palette of genetically encoded molecular reporters. However, the field still requires robust and label-free technologies to monitor the multifaceted biomolecular changes accompanying brain development, aging or disease. Here, we have developed vibrational fiber photometry as a low-invasive method for label-free monitoring of the biomolecular content of arbitrarily deep regions of the mouse brain in vivo through spontaneous Raman spectroscopy.

Advantages of internal reference in holographic shaping ps supercontinuum pulses through multimode optical fibers.

The use of wavefront shaping has found extensive application to develop ultra-thin endoscopic techniques based on multimode optical fibers (MMF), leveraging on the ability to control modal interference at the fiber's distal end. Although several techniques have been developed to achieve MMF-based laser-scanning imaging, the use of short laser pulses is still a challenging application. This is due to the intrinsic delay and temporal broadening introduced by the fiber itself, which requires additional compensation optics on the reference beam during the calibration procedure.

Potential of plasmonics and nanoscale light-matter interactions for the next generation of optical neural interfaces.

Within the realm of optical neural interfaces, the exploration of plasmonic resonances to interact with neural cells has captured increasing attention among the neuroscience community. The interplay of light with conduction electrons in nanometer-sized metallic nanostructures can induce plasmonic resonances, showcasing a versatile capability to both sense and trigger cellular events. We describe the perspective of generating propagating or localized surface plasmon polaritons on the tip of an optical neural implant, widening the possibility for neuroscience labs to explore the potential of plasmonic neural interfaces.

Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes.

Introduction: Despite the improvements of insulin therapy, people with type 1 diabetes (T1D) still suffer from a decreased quality of life and life expectancy. The search toward a cure for T1D is therefore still a scorching open field of research.

Areas Covered: Tackling the immune checkpoint signaling pathways has gained importance in the field of cancer immunotherapy.